HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

poly(ethylene glycol) lysine copolymer

structure given in first source

Also Known As:

poly(PEG-Lys); poly(ethylene glycol)-b-poly(L-lysine)

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Jiang, Haiying: 1 article (01/2017)
2.	Liu, YuJuan: 1 article (01/2017)
3.	Shan, Fang: 1 article (01/2017)
4.	Tong, Fei: 1 article (01/2017)
5.	Cai, Lintao: 1 article (01/2016)
6.	Li, Ping: 1 article (01/2016)
7.	Liu, Lanlan: 1 article (01/2016)
8.	Ma, Yifan: 1 article (01/2016)
9.	Pan, Hong: 1 article (01/2016)
10.	Sheng, Nan: 1 article (01/2016)

Related Diseases

1.	Neoplasms (Cancer) 10/14/2015 - "Tumor-targeting, redox-responsive and high drug-loaded nanoparticles were synthesized from poly(ethylene glycol)-b-poly(l-lysine) (PEG-PLL) for enhanced cancer therapy. " 01/01/2016 - "In the present study, we developed self-cross-linked biodegradable poly(ethylene glycol)-b-poly(l-lysine)-b-poly(l-cysteine) (LCss) polypeptide nanoparticles to codeliver DOX and miR-129-5p, which aimed to overcome MDR in cancer cells. "
2.	Reperfusion Injury 01/01/2022 - "In vitro and in vivo Protein Release and Anti-Ischemia/Reperfusion Injury Properties of Bone Morphogenetic Protein-2-Loaded Glycyrrhetinic Acid-Poly(Ethylene Glycol)-b-Poly(L-Lysine) Nanoparticles [Retraction]." 01/01/2017 - "In vitro and in vivo protein release and anti-ischemia/reperfusion injury properties of bone morphogenetic protein-2-loaded glycyrrhetinic acid-poly(ethylene glycol)-b-poly(l-lysine) nanoparticles."

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	Cysteine (L-Cysteine)
3.	Proteins (Proteins, Gene)
4.	Glycyrrhetinic Acid (Po 12)

Related Therapies and Procedures

1.	Therapeutics